Cite

HARVARD Citation

    Ogbuagu, O. et al. (2021). Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 8 (7), pp. e397-e407. [Online]. 
  
Back to record